Preclinical studies of GBS-induced sepsis showed that GBS-driven inflammation was mainly driven by TLR2/6 and β-hemolysin/ (NLR)-P3 pathways and IL-1 (13–16). This evidence concerns the gene TLR2 and Sepsis.